Atypical hemolytic uremic syndrome (aHUS) is a rare cause of thrombotic microangiopathy
(TMA), characterized by microangiopathic hemolytic anemia, consumptive …

Secondary hemolytic uremic syndrome (HUS) is a heterogeneous group of thrombotic
microangiopathies associated with various underlying conditions. Whether it belongs to the …

The 3 major thrombotic microangiopathies (TMAs) are thrombotic thrombocytopenic purpura
(TTP), atypical hemolytic uremic syndrome (aHUS), and Shiga toxin–producing Escherichia …

Atypical hemolytic uremic syndrome (aHUS) is a disease characterized by the triad of
microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury. The …

The haemolytic uraemic syndrome (HUS) includes the triad of haemolytic anaemia,
thrombocytopenia, and acute renal failure. The classical form [D (+) HUS] is caused by …

Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy caused by
uncontrolled activation of the alternative pathway of complement at the cell surface level that …

Hemolytic uremic syndrome (HUS) is a clinical syndrome characterized by the triad of
thrombotic microangiopathy, thrombocytopenia, and acute kidney injury. Hemolytic uremic …

Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is
characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal …

Mutations in the complement regulators factor H, membrane cofactor protein (MCP), and
factor I are associated with atypical hemolytic uremic syndrome (aHUS, MIM 235400) …

Haemolytic uraemic syndrome (HUS) is a heterogeneous group of diseases that result in a
common pathology, thrombotic microangiopathy, which is classically characterised by the …